Indications for and Adverse Effects of Red-Cell Transfusion.

Advances in clinical research have led to reduced use of blood products. Judicious use has reduced the incidence of lung injury and circulatory overload. Testing of blood products for infectious agents has reduced their transmission.

[1]  B. Crookes.  Transfusion Strategies for Acute Upper Gastrointestinal Bleeding , 2019, 50 Landmark Papers.

[2]  J. Hamdorf,et al.  Improved outcomes and reduced costs associated with a health‐system–wide patient blood management program: a retrospective observational study in four major adult tertiary‐care hospitals , 2017, Transfusion.

[3]  M. Sapiano,et al.  Continued decline in blood collection and transfusion in the United States–2015 , 2017, Transfusion.

[4]  S. Kleinman,et al.  Incidence and clinical characteristics of transfusion‐associated circulatory overload using an active surveillance algorithm , 2017, Vox sanguinis.

[5]  S. Stramer,et al.  Screening for Babesia microti in the U.S. Blood Supply. , 2016, The New England journal of medicine.

[6]  Sunil V. Rao,et al.  Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. , 2016, JAMA.

[7]  A. Cifu,et al.  Transfusion of Red Blood Cells. , 2016, JAMA.

[8]  H. Ddungu,et al.  Cerebral Oximetry in Ugandan Children With Severe Anemia: Clinical Categories and Response to Transfusion. , 2016, JAMA pediatrics.

[9]  Yi Mu,et al.  Declining blood collection and utilization in the United States , 2016, Transfusion.

[10]  J. McCullough,et al.  Transfusion-Transmitted Babesia microti. , 2016, Transfusion medicine reviews.

[11]  S. Kleinman,et al.  Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey , 2016, Transfusion.

[12]  H. Kamel,et al.  A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors , 2016, Transfusion.

[13]  J. Allain,et al.  Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial , 2016, The Lancet.

[14]  R. Davenport.  Hemolytic transfusion reactions , 2016 .

[15]  T. Walsh,et al.  Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis , 2016, British Medical Journal.

[16]  V. Compernolle,et al.  Methodologic quality assessment of red blood cell transfusion guidelines and the evidence base of more restrictive transfusion thresholds , 2016, Transfusion.

[17]  H. Ddungu,et al.  Effect of Transfusion of Red Blood Cells With Longer vs Shorter Storage Duration on Elevated Blood Lactate Levels in Children With Severe Anemia: The TOTAL Randomized Clinical Trial. , 2015, JAMA.

[18]  T. Walsh,et al.  Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial , 2015, The Lancet.

[19]  H. Mutneja,et al.  Liberal or Restrictive Transfusion after Cardiac Surgery. , 2015, The New England journal of medicine.

[20]  E. Murphy,et al.  Transfusion-associated circulatory overload (TACO): prevention, management, and patient outcomes , 2015 .

[21]  L. Fleisher,et al.  Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial , 2015, The Lancet.

[22]  J. Binnekade,et al.  Low‐risk transfusion‐related acute lung injury donor strategies and the impact on the onset of transfusion‐related acute lung injury: a meta‐analysis , 2015, Transfusion.

[23]  Jianxia Sun,et al.  Risk factors of community-associated infections in Chinese patients with diabetes: A meta-analysis , 2015, Journal of translational internal medicine.

[24]  V. Pettilä,et al.  Lower versus higher hemoglobin threshold for transfusion in septic shock. , 2014, The New England journal of medicine.

[25]  A. Shander,et al.  An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME) , 2014, Transfusion.

[26]  A. Alayash.  Blood substitutes: why haven't we been more successful? , 2014, Trends in biotechnology.

[27]  P. Vyas,et al.  Guidelines for the diagnosis and management of adult myelodysplastic syndromes , 2014, British journal of haematology.

[28]  Paul Shekelle,et al.  Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians , 2013, Annals of Internal Medicine.

[29]  H. Gombotz,et al.  Patient Blood Management , 2013, Der Anaesthesist.

[30]  Regina M. Hardison,et al.  Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. , 2013, American heart journal.

[31]  C. Prowse,et al.  Component pathogen inactivation: a critical review , 2013, Vox sanguinis.

[32]  Susan R. Wilcox,et al.  Massive transfusion in traumatic shock. , 2013, The Journal of emergency medicine.

[33]  R. Pearse,et al.  Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients , 2013, British journal of haematology.

[34]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[35]  M. Poca,et al.  Transfusion strategies for acute upper gastrointestinal bleeding. , 2013, The New England journal of medicine.

[36]  M. Cappellini,et al.  How I treat transfusional iron overload. , 2012, Blood.

[37]  S. Montgomery,et al.  The United States Trypanosoma cruzi Infection Study: evidence for vector‐borne transmission of the parasite that causes Chagas disease among United States blood donors , 2012, Transfusion.

[38]  J. Adamson,et al.  Notice , 2012, Kidney International Supplements.

[39]  J. Muñoz-Jordán,et al.  Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico , 2012, Transfusion.

[40]  A. Migliaccio,et al.  Ex-vivo expansion of red blood cells: how real for transfusion in humans? , 2012, Blood reviews.

[41]  R. Weiskopf,et al.  Transfusion-related acute lung injury: incidence and risk factors. , 2012, Blood.

[42]  D. Triulzi,et al.  Transfusion‐associated circulatory overload after plasma transfusion , 2012, Transfusion.

[43]  B. Chaitman,et al.  Liberal or restrictive transfusion in high-risk patients after hip surgery. , 2011, The New England journal of medicine.

[44]  Roger Y Dodd,et al.  Nucleic acid testing to detect HBV infection in blood donors. , 2011, The New England journal of medicine.

[45]  G. Foster,et al.  Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing , 2010, Transfusion.

[46]  M. Arango,et al.  Near-infrared spectroscopy as an index of brain and tissue oxygenation. , 2009, British journal of anaesthesia.

[47]  E. Vamvakas,et al.  Immunomodulatory and Proinflammatory Effects of Allogeneic Blood Transfusion , 2009 .

[48]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[49]  Peter Tomasulo,et al.  Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. , 2005, The New England journal of medicine.

[50]  Jürgen Neppert,et al.  Re: Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel , 2005, Transfusion.

[51]  Edward Abraham,et al.  Transfusion-related acute lung injury: definition and review. , 2005, Critical care medicine.

[52]  M. Brecher,et al.  Bacterial Contamination of Blood Components , 2005, Clinical Microbiology Reviews.

[53]  Robertson Davenport,et al.  Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel , 2004, Transfusion.

[54]  J. Fridey,et al.  Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. , 2004, Blood.

[55]  Sally Caglioti,et al.  Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. , 2004, The New England journal of medicine.

[56]  M. Parise,et al.  Transfusion-transmitted malaria in the United States from 1963 through 1999. , 2001, The New England journal of medicine.

[57]  Jerod M. Loeb,et al.  To err is human: an interview with the Institute of Medicine's Linda Kohn. , 2000 .

[58]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[59]  A. Grindon,et al.  Predictive value of past and current screening tests for syphilis in blood donors: changing from a rapid plasma reagin test to an automated specific treponemal test for screening , 1999, Transfusion.

[60]  J. Berlin,et al.  Effect of anaemia and cardiovascular disease on surgical mortality and morbidity , 1996, The Lancet.

[61]  C. Nass,et al.  Blood donor testing for HIV-I/II and HTLV-I/II. , 1994, Archives of pathology & laboratory medicine.

[62]  R. Greenhalgh,et al.  Effect of early blood transfusion on gastrointestinal haemorrhage , 1986, The British journal of surgery.

[63]  T. Connor,et al.  Renal handling of calcium and phosphate during mineralocorticoid "escape" in man. , 1972, Kidney international.

[64]  L. Katz,et al.  Zika and the Blood Supply: A Work in Progress. , 2017, Archives of pathology & laboratory medicine.

[65]  A. Abuchowski.  PEGylated Bovine Carboxyhemoglobin (SANGUINATE™): Results of Clinical Safety Testing and Use in Patients. , 2016, Advances in experimental medicine and biology.

[66]  J. Stockman.  Proof of principle for transfusion of in vitro–generated red blood cells , 2013 .

[67]  J. Ajani,et al.  Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[68]  D. Gerber.  Conservative Versus Liberal Red Cell Transfusion in Acute Myocardial Infarction (the CRIT Randomized Pilot Study) , 2012 .

[69]  R. Purcell,et al.  Hepatitis E , 2013, Water and Sanitation for the 21st Century: Health and Microbiological Aspects of Excreta and Wastewater Management (Global Water Pathogen Project).

[70]  J. Carson,et al.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2012, The Cochrane database of systematic reviews.

[71]  J.,et al.  The New England Journal of Medicine , 2012 .

[72]  A. Powers,et al.  Chikungunya virus: possible impact on transfusion medicine. , 2010, Transfusion medicine reviews.

[73]  J. Stockman.  Transfusion Strategies for Patients in Pediatric Intensive Care Units , 2009 .

[74]  P. Rhee,et al.  Tissue oxygen saturation predicts the development of organ dysfunction during traumatic shock resuscitation. , 2007, The Journal of trauma.

[75]  Arialdi M. Miniño,et al.  Deaths: final data for 2008, United States , 2006 .

[76]  M. Bissell.  Detection of HIV-1 and HCV Infections Among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing , 2006 .

[77]  J. Freedman,et al.  Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction. , 2001, Transfusion medicine reviews.

[78]  W. A. Zellmer.  Toward understanding. , 1988, American journal of hospital pharmacy.

[79]  Saudi Arabia,et al.  in the United States and in , 1981 .